Friday, April 26, 2024 4/26/2024

Role of receptor-interacting serine/threonine-protein kinase 3 (RIPK3) in Herpes Simplex Virus (HSV) Encephalitis

Award Number: R21AI175590
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

This project, “Role of receptor-interacting serine/threonine-protein kinase 3 (RIPK3) in Herpes Simplex Virus (HSV) Encephalitis”, aims to define the precise contribution of RIPK3 to Herpes Simplex Virus (HSV)-1 pathogenesis by using the experimental Herpes Simplex Encephalitis (HSE) model. We have found that RIPK3 kinase-dependent necroptosis restricts HSV-1 replication in human cells as well as mouse cells. The attenuation of HSV-1 propagation in mice was attributed to RIPK3-mediated necroptosis in current literature. Little information is available about the precise contribution of RIPK3 toward onset and development of the life- threatening virus-induced encephalitis. Using a well-accepted mouse model of HSE and unique knock-in/out mice, we have now obtained new evidence suggesting that RIPK3 restricts HSV-1-induced encephalitis via a RIPK3-necroptosis independent scaffolding function in the central nervous system (CNS), which requires caspase 8 function. The mechanism through which RIPK3 collaborates with caspase 8 to restrict HSE will be determined over the course of the project. Two complementary and interrelated research directions will be pursued. Specific Aim 1 will test the hypothesis that HSV1 infection drives RIPK3 activation of caspase 8- mediated apoptosis in microglia to restrict pathogenesis of HSV1-induced encephalitis. Specific Aim 2 will test the hypothesis that RIPK3 scaffolding function coordinates protective neuroinflammation and dictates antiviral immune response to restrict pathogenesis of HSV1-induced encephalitis. Ultimately, we expect to (1) establish that RIPK3 scaffolding function, by collaborating with caspase 8, is important for HSE restriction rather than the kinase activity, and (2) show that RIPK3 regulates brain inflammation via stimulation of key proinflammatory cytokines/chemokines. The studies proposed herein are intended to fill a major existing knowledge gap in our understanding of the RIPK3 and the pathogenesis of HSE. The impact on the field of HSE will include establishing fundamental mechanisms of targeting RIPK3 signaling therapeutically towards diagnosing, preventing, and/or treating this life-threatening virus-induced encephalitis in human settings.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $164,250 )
2024	2024	LOUISIANA STATE UNIVERSITY	1501 KINGS HWY	SHREVEPORT	LA	71103	CADDO	USA	Allergy and Infectious Diseases Research	000	2	12/19/2023	NON-COMPETING CONTINUATION	$164,250
														Subtotal = $164,250

Issue Date FY: 2023 ( Subtotal = $219,000 )
2023	2023	LOUISIANA STATE UNIVERSITY	1501 KINGS HWY	SHREVEPORT	LA	71103	CADDO	USA	Allergy and Infectious Diseases Research	000	1	2/15/2023	NEW	$219,000
														Subtotal = $219,000

Grand Total All Awards = $383,250

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role of receptor-interacting serine/threonine-protein kinase 3 (RIPK3) in Herpes Simplex Virus (HSV) Encephalitis

Award Number: R21AI175590

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer